Proton Radiation For Chordomas and Chondrosarcomas
This trial will be conducted in two phases: a feasibility then a phase II trial. Once
feasibility and safety are established in the first 12 pts. the phase II study will begin.
Proton therapy at standard doses is not known to improve clinical outcome but will likely
reduce fatigue and toxicity.
Primary Purpose: Treatment
patient is unable to complete all of his/her treatments with 10 days of estimated date of treatment completion or requires a treatment breaks greater than 5 days.
Up to 10 days
United States: Institutional Review Board
|Abramson Cancer Center of the University of Pennsylvania||Philadelphia, Pennsylvania 19104-4283|